Canadian AI Technology Revolutionizes Early Detection of ALS

Groundbreaking Canadian AI Technology Revolutionizes Early Detection of ALS

In a remarkable stride towards advancing healthcare, Canadian innovators have unveiled a groundbreaking artificial intelligence (AI) program to transform the early detection of Amyotrophic Lateral Sclerosis (ALS). Mitsubishi Tanabe Pharma Canada (MTP-CA) takes immense pride in supporting this revolutionary AI technology, which harnesses the power of AI to scrutinize de-identified electronic medical records (EMRs). This…

Revolutionizing Antibody Design: Harnessing the Power of Generative AI

Revolutionizing Antibody Design: Harnessing the Power of Generative AI

Introduction The field of generative artificial intelligence has seen remarkable advancements in recent years, enabling machines to create images and generate text. However, its potential goes far beyond art and literature. Absci Corporation, a pioneering company in antibody therapeutics, is leveraging generative AI to revolutionize drug discovery. By harnessing the power of machine learning, Absci can…